Safe Practices to Decrease the Inherent Risk of High Alert - - PowerPoint PPT Presentation

safe practices to decrease the inherent risk of high
SMART_READER_LITE
LIVE PREVIEW

Safe Practices to Decrease the Inherent Risk of High Alert - - PowerPoint PPT Presentation

Safe Practices to Decrease the Inherent Risk of High Alert Medications Meghan Duck, RNC-OB, MS, CNS Perinatal Outreach UCSF Benioff Childrens Hospital May 2018 1999 IOM Report To Err is Human: Building a Safer Health System An estimated


slide-1
SLIDE 1

Safe Practices to Decrease the Inherent Risk of High Alert Medications

Meghan Duck, RNC-OB, MS, CNS Perinatal Outreach UCSF Benioff Children’s Hospital

May 2018

slide-2
SLIDE 2

An estimated 44,000 - 98,000 people die each year from medical errors in hospitals “The equivalent of a jumbo jet crashing every day” New studies have shown these numbers are increasing.

Khon 2000, Wachter 2004

1999 IOM Report To Err is Human: Building a Safer Health System

slide-3
SLIDE 3

To err is human….

▪ The health reporter for the Boston Globe….

  • Betsy Lehman died from chemo overdose

▪ Additionally

  • Willie King had the wrong leg amputated
  • Ben Kolb (8yrs old)

‒ died during minor surgery ‒ Drug mix up

slide-4
SLIDE 4

Preventable Medical Errors ranked above Diabetes, Alzheimer’s, and Influenza A 2016 follow-up to the IOM study by Johns Hopkins researchers found medical errors were underestimated.

  • medication errors → most common mistakes
  • harming ≥ 1.5 million people per year
  • ~ 400,000 preventable drug-related injuries per year

HU HUGE GE PROBLEM OBLEM

slide-5
SLIDE 5

From 1999 to 2016: What happened?

slide-6
SLIDE 6

Even the best…. Can make a mistake

Severe outcomes of medical errors

  • Unnecessary blood transfusions
  • Unnecessary cesarean birth
  • Prolonged hospitalization
  • Intrapartum fetal death
  • Neonatal death
  • Maternal death

High Alert Medications

Oxytocin Magnesium Epidural infusion Opioids Heparin Insulin

  • Well-rested/fed
  • Highly confident
  • Highly motivated
slide-7
SLIDE 7

Institute of Medicine

▪ Some Background ▪ 1998 The Quality of Healthcare in America project ‒ Develop a strategy that will improve quality

‒ Review and synthesize literature ‒ Develop communication strategies ‒ Articulate framework of incentives/foster accountability ‒ Identify factors that improve quality of care ‒ Develop research agenda

slide-8
SLIDE 8

To err…is expensive

▪ Medication errors cause temporary harm, ▪ Disability, and death ▪ The human costs are incalculable ▪ The financial cost is estimated, and very likely underestimated.

  • ≥ $17.1 billion every year
  • Range found in literature

▪Most common reason for malpractice lawsuits

  • Average amount awarded by the courts is $3.1 million

HHS 2010

slide-9
SLIDE 9

Bringing it back to basics…

  • Right Patient
  • Right Route
  • Right Dose
  • Right Time
  • Right Medication
slide-10
SLIDE 10

Medical Errors vs. Adverse Events

▪Medical Error- “ The failure to complete a planned action as intended or the use of a wrong plan to achieve an aim” (IOM) ▪Adverse Event- “ An injury caused by medical management rather than by the underlying disease or condition of the patient.”

slide-11
SLIDE 11

Medication Use Process

Any interruptions along the way of this path can cause errors and lead to adverse outcomes.

slide-12
SLIDE 12

Reconciliation

▪ Systematic validation and verification of medical history and

  • rders

▪ It involves comparing a patient’s current drug prescription with all medications currently taken ▪ It should be undertaken at every transition of care. ▪ Top causes of reconciliation errors include:

  • Performance deficit
  • Transcription documentation
  • Communication interruption
  • Work flow interruption

Avoid omissions Duplications Dose errors Drug interactions

slide-13
SLIDE 13

Med Reconciliation

▪ There are 5 main steps: ▪ 1) develop a list of current medications ▪ 2) develop a list of medications to be prescribed ▪ 3) compare the medications on the two lists ▪ 4) make clinical decisions based on the comparison ▪ 5) communicate the new list to appropriate caregivers and to the patient.

slide-14
SLIDE 14

One Study: Reported medication errors by unit

▪Labor & Delivery 2218 48.4 ▪Maternity Unit 2143 46.8 ▪OB PACU/Recovery 222 4.8 ▪Total 4583 100

Obstetrical Area n Percent

Kfuri et al. (2008) Data from 1/1/2003 – 12/31/2005

slide-15
SLIDE 15

Example from PA:

slide-16
SLIDE 16

System factors that influence errors

▪Staffing Levels – high nurse/pt ratio, rushing, no breaks ▪RN skill mix – heavy burden ▪Shift length – 12h (3X’s ) v/s 8h, also time of day/week ▪Patient acuity – higher stress on RN ▪Organizational climate

slide-17
SLIDE 17

Other factors contributing to med errors by nurses Long work hours – shifts ▪Fatigue ▪Inefficient care process ▪Workplace design ▪Workload of documentation ▪Lack of knowledge of medication ▪Sources Institute of Medicine and Hewitt ▪Mathematical errors ▪Environmental stressors ▪Communication problems ▪Not following the 5 Rights ▪Look alike/ Sound alike medications

slide-18
SLIDE 18

Swiss Cheese Model- med errors

slide-19
SLIDE 19

Nurse leaders want to know: Why are nurses not following the 5 rights?

▪Do nurses lose interest over time? ▪Is it because they are no longer being observed? ▪Are they overburdened with heavy workloads ▪Are they emotionally affected?

slide-20
SLIDE 20
  • Incompetent – they aren’t qualified
  • Guilty – they were careless
  • Scared – something punitive will happen
  • Worried – harm will result for the patient
  • Afraid – co workers disrespect /reactions
  • Distracted-interrupted during the process
slide-21
SLIDE 21

Professional Nurse ”knowledge workers”

▪Described as people who think for a living ▪Valued by society for their:

  • education/ knowledge
  • expertise in a specific subject/area

▪Must have high quality cognitive processing ability ▪Patients/ Family may interpret as:

  • Not focusing on them
  • We appear as thought we are distracted
  • Not caring – Not listening

▪Our brain is busy “juggling”

slide-22
SLIDE 22
slide-23
SLIDE 23

Cognitive Neuroscience Research Factors that can influence errors:

▪Interruptions - q 11 minutes / 25 minutes to resume ▪Distractions

  • Internal
  • mind wandering

‒ Requires complex mental activity to control

slide-24
SLIDE 24

External

‒Requires anticipatory planning – i.e. vests, zones

  • Inhibiting distractions early before they gain

momentum is difficult and cannot easily be controlled. ▪Multitasking ▪Lack of focus ▪Task switching

slide-25
SLIDE 25

Cognitive Neuroscience Research How does the brain deal with multitasking?

▪The human brain

  • can make only 1 decision at a time

▪Back and forth when trying to simultaneously process

  • Loss of accuracy
  • Takes more time switching back and forth

▪Maximum # of items people can consciously hold is  4 ▪The ability to switch is diminished with age

Clark, A. et al. (2012) Clinical Nurse Specialists

slide-26
SLIDE 26

Strategies: Reduce errors during administration

▪Avoid engaging in nonessential communication ▪Medication administration checklist ▪Teamwork: having other staff cover telephone calls and interruptions

  • Special garment (vest or sash)
  • No Interruption Zone
  • Scripting for when nurses are interrupted

Flanders & Clark; Clinical nurse specialist (2010), vol 24 (6)

slide-27
SLIDE 27

Older Nurses

▪ Older adults fared differently when compared to young adults ▪ N = 40 20 ~age 24.5 Y=20 with ~ 20 ~age 69 ▪ Older –

  • more difficulty letting go of distraction
  • Slower to regain focus on 1st task

▪ Aging does appear to cause loss of multitasking function ▪ It’s more difficult to switch tasks easily ▪ Older nurses often likely to be pulled ▪ Respectful approach

slide-28
SLIDE 28

Error Analysis-influential factors

▪Maintain Safety ▪Manage the environment

  • Distractions – phone calls, family questions, pulled

away

  • 29.3% - interrupted by other nurses
  • 22.8% - system failure (missing medication)

▪3 level of errors have been identified 1.Skill based (slips and lapses) 2.Rule based (poor choices or inappropriate rules) 3.Knowledge-based (apply thinking to new situation)

slide-29
SLIDE 29

Reporting Medication Errors

▪Medication errors are under reported

  • It’s estimated only 1 out of every 5 dose errors are

reported Brady, A., et al. (2009).

  • Confusion regarding definition of a medication error

Gladstone, 1995; Mayo et al., 2004; Ulanimo et al., 2007

  • Nurses did not believe “right time was as crucial as other

five rights

  • Timing is part of nursing judgment
  • Stetina, et al., (2005)
slide-30
SLIDE 30

▪Uncertainty if the medication error must be reported ▪Fear of disciplinary action if medication error is reported ▪Therefore evaluation to identifying root causes

  • f medication errors is obscured by these factors
  • Gladstone. J. (1995)
slide-31
SLIDE 31

Questions

▪What is the process for administering medications at your institution? ▪How has this process changed since you entered nursing? ▪What do you consider a medication error? ▪What procedures exists to decrease medication errors on your unit? ▪What is the role of pharmacy/technology in preventing med errors?

slide-32
SLIDE 32

▪What is the process for reporting medication errors at your institution? ▪If you have made a medication error, and are willing, please respond to the following:

  • Give an example of a time you found a med error

and reported it.

  • Give an example of a time you found a med error and

did not report it. ▪How would you change the process of reporting med errors today?

slide-33
SLIDE 33

High Alert Medications used in OB

▪Andrenergic agonists

  • Epinephrine

▪Andrenergic antagonists

  • Labetalol

▪Anticoagulants

  • Heparin, Warfarin

▪Dextrose ▪Epidural medications ▪Insulin, Oral Hypoglycemics ▪Narcotics ▪Specifics

  • Magnesium
  • Oxytocin
  • Promethazine
slide-34
SLIDE 34
slide-35
SLIDE 35

2008 Consensus Report Standards for Perinatal Care

The safe practices are defined as: processes that should be universally used in healthcare settings to: reduce the risk of harm resulting from:

  • processes
  • systems
  • environments of

care

slide-36
SLIDE 36

Update from NQF’s 2012 Perinatal and Reproductive Health Measures

  • NQF is a private nonprofit organization that develops and

implements a national strategy for healthcare quality measurement and reporting.

  • NQF analyzed the available scientific evidence to define a

set of practices targeted at improving patient safety.

  • Endorsed 14 of 21 measures to increase perinatal safety.
slide-37
SLIDE 37

Case Presentation

  • 29 yo @30+2 arrives from ED 4:30 pm Friday
  • G3 / P0, BMI = 40
  • Vaginal bleeding (~500mL gush)
  • Hx: 2001 dx CHTN, 2008 Artificial Heart Valve
  • Hx: 2009 Left side CVA (Stroke)
  • Hospitalized twice for CHF: 2010, 2011
  • Anticoagulated with Warfarin – target INR 2.5
  • Medications: 3 anti-HTN agents to control BP
  • Bedside U/S reveals ~ 350-500mL clot (abruption)

– T = 98.0 – HR = 92 – BP = 132/92 – R = 20

Questions:

  • Risk factors
  • Assessment
  • SBAR

VS:

slide-38
SLIDE 38

Cardiovascular Risk

  • Embolic Stroke
  • Clot forms in the heart
  • Travels to the brain
  • Hemorrhagic Stroke
  • Blood vessel ruptures
  • Damages the brain
slide-39
SLIDE 39

Heparin

▪2007 Dennis Quaid’s twins were given 1000-fold

  • verdose because heparin was mis-stocked in the

Automated Dispensing Cabinets (ADC) Pyxis ▪At that time the packaging for heparin and heparin lock flush were very similar ▪Bar code scan was developed to correct the process error Chasing Zero

slide-40
SLIDE 40

Bar Code Medication Administration

▪BCMA brings trade-offs

  • Human automation
  • Lean Approach
  • Procedure violation

‒ When Hard Stops fail

  • Work arounds
  • Work flow
slide-41
SLIDE 41

Medication Safety Initiatives The Big Three

  • 1. Computerized provider order entry (CPOE)
  • 2. Bar code medication administration (BCMA)
  • 3. Smart IV Pumps
slide-42
SLIDE 42

Unfractionated Heparin

▪for PE

  • Loading dose: 150 units/kg bolus
  • 15-25 units/kg/hr
  • Transition to SQ or low molecular weight heparin

▪Side effects

  • Hemorrhage, hypotension

‒ Protamine sulfate 1mg neutralizes 100 units of heparin ▪ Should not exceed 50 mg

▪Initial treatment in single dose

slide-43
SLIDE 43

▪Follow aPTT 4 hours after initiation and after dose changes ▪Goal with heparin therapy: aPTT 1.5 -2.5 x control (60-80 seconds) ▪Monitor coagulation lab trends ▪Risk of epidural or spinal hematoma

slide-44
SLIDE 44

Magnesium Sulfate

  • Mechanism

– Calcium antagonist Inhibits voltage independent calcium channels at the myometrial cell surface

  • Efficacy

– Not confirmed – Cochrane review

  • Rationale

– Safe and familiar, neuroprotective

  • Safety and side effects

– Flushing, nausea, blurred vision, headache, pulmonary edema, cardiac arrest - caution if creat >1.0

ACOG Practice Bulletin. #43, 2003 Iams, J. Obstetrics: Normal and Problem Pregnancies, 4th d., 2002; Preterm birth, Williams Obstetrics, 22nd ed., 2005.

#1 Tocolytic used in the U.S.

slide-45
SLIDE 45

Management

  • Magnesium sulfate given for seizure prophylaxis
  • 4 - 6 g loading dose→ 1-2 g per hour maintenance dose

▪ Magpie trial established 1 gm/hr dose effective ▪ Controversy over whether MgSO4 is needed in mild preeclampsia when closely monitored

  • Treatment usually continues for 24 hours after birth
  • Most common preventable errors in preeclampsia mgmt

leading to maternal death involved inattention to BP control and S/S of pulmonary edema

Clark, S. Maternal death in the 21st Century. Am J Obstet Gynecol, 2008

slide-46
SLIDE 46

Development of the California Toolkit ‘Improving Health Care Response to Preeclampsia’ was funded by the California Department of Public Health (CDPH), Center for Family Health, Maternal Child and Adolescent Health (MCAH) Division, using federal Title V MCH funds.

CMQCC Preeclampsia Toolkit Preeclampsia Task Force Members

Maurice Druzin, MD – Stanford

Elliott Main, MD – CMQCC Barbara Murphy, RN – CMQCC Tom Archer, MD – UCSD Ocean Berg, RN, CNS – SF General Hospital Brenda Chagolla, RNC, CNS – UC Davis Holly Champagne, RNC, CNS – Kaiser Meredith Drews – Preeclampsia Foundation Racine Edwards-Silva, MD – UCLA Olive View Kristi Gabel, RNC CNS – RPPC Sacramento Thomas Kelly, MD – UCSD Claire Brindis, DrPH, UCSF Dana Hughes, DrPH, UCSF

Larry Shields, MD – Dignity Health

Nancy Peterson, RNC, PNNP – CMQCC Christine Morton, PhD – CMQCC Sarah Kilpatrick, MD – Cedars Sinai Richard Lee, MD – Univ. of Southern California Audrey Lyndon PhD, RNC – UC San Francisco Mark Meyer, MD – Kaiser SD Valerie Cape – CMQCC Eleni Tsigas – Preeclampsia Foundation Linda Walsh, PhD, CNM – UC San Francisco Mark Zakowski, MD – Cedars Sinai Alana Moore Michael Orosco, MD ,Kaiser San Diego

4

slide-47
SLIDE 47

Magnesium for Eclampsia

▪4 – 6 grams bolus over 15 -20 min per institution P&P

  • ACOG, CMQCC

▪For eclampsia – use smart pump (Alaris) library ▪2 RN check ▪RN remains at bedside for duration of bolus (staffing?)

  • Antidote: Give 10% Calcium Gluconate 10ml (1

gram) slow IV push over 3 minutes ‒Calcium Gluconate override from Pyxis ❖may repeat every hour, if needed, up to eight

doses/24 hours

slide-48
SLIDE 48

Severe Preeclampsia

▪Each institution should prepare its own medication toolbox specific to its protocols

  • Labetalol 20 mg IV bolus → 40mg → 80mg (max 300mg)
  • Hydralazine 5- 10mg doses every 15-20 minutes
  • Nifedipine 10 mg PO repeat every 30 minutes
  • Labetalol 200mg PO repeat every 30 minutes
  • Esmolol 1-2 mg/kg IV over 1 minute
  • Propofol 30-40 mg IV bolus
slide-49
SLIDE 49

Magnesium Sulfate - Root Causes

Conditions that make accidents more likely

▪Different protocols, policies, procedures from one unit to another ▪Multiple pump settings ▪Inadequate labeling of IV fluids ▪Not removing the Magnesium from the IV port when it is has been discontinued ▪Thinking women on Magnesium are “stable” ▪Assumptions and miscommunication between nurses and/or physicians

slide-50
SLIDE 50

ACOG Executive Summary on Hypertension In Pregnancy, Nov 2013

1to diagnose preeclampsia with new onset hypertension.

  • 3. The total amount of proteinuria > 5g in 24 hours has been

eliminated from the diagnosis of severe preeclampsia.

  • 4. Early treatment of severe hypertension is mandatory at the

threshold levels of 160 mm Hg systolic or 110 mm Hg diastolic. The term “mild” preeclampsia is discouraged for clinical classification. The recommended terminology is:

  • a. “preeclampsia without severe features” (mild)
  • b. “preeclampsia with severe features” (severe)
  • 2. Proteinuria is not a requirement

18

slide-51
SLIDE 51

ACOG Executive Summary on Hypertension In Pregnancy Nov 2013

  • 5. Magnesium sulfate for seizure prophylaxis is indicated for

severe preeclampsia and should not be administered universally for preeclampsia without severe features (mild).

  • 6. Preeclampsia with onset prior to 34 weeks is most often

severe and should be managed at a facility with appropriate resources for management of serious maternal and neonatal complications.

  • 7. Induction of labor at 37 weeks is indicated for preeclampsia

and gestational hypertension.

19

slide-52
SLIDE 52

ACOG Executive Summary on Hypertension In Pregnancy Nov 2013

  • 8. The postpartum period is potentially dangerous. Patient

education for early detection during and after pregnancy is important.

  • 9. Long-term health effects of magnesium should be

discussed.

slide-53
SLIDE 53

CMQCC Preeclampsia Toolkit Key Clinical Pearls

▪Use of preeclampsia-specific checklists, team training and communication strategies, and continuous process improvement strategies will likely reduce hypertensive related morbidity. ▪Use of patient education strategies, targeted to the educational level of the patients, is essential for increasing patient awareness of signs and symptoms of preeclampsia.

71

slide-54
SLIDE 54

Example Case

A 27 y.o was admitted to L&D with cramping, abdominal pain, vaginal bleeding and leaking of clear fluid at 27 wks In an attempt to stop preterm labor, the OB prescribed IV magnesium sulfate with a 6 g bolus dose over 30 min followed by a continuous infusion of 2g/hr A 20g/500ml bag of magnesium was used and the smart pump was programmed to deliver a continuous infusion at 12 g/hr

slide-55
SLIDE 55

The rest of the story

The pt. became flushed, short of breath, she called for a nurse. The pt was found felling dizzy and hypotensive and quickly proceeded to become unresponsive CPR was initiated, magnesium infusion stopped and she was given a dose of Ca Gluconate The pt responded to emergency treatment - the baby was delivered by C/S a few days later d/t unrelated preterm complications Both mom and baby were discharged w/o harm?

slide-56
SLIDE 56

Common Factors in MgSO4 Deaths

▪Use of 1,000ml IV bags w/40 g of MgSO4 ▪Temporary removal of the IV line from the IV pump ▪A busy unit and/or understaffing ▪Transfer to a lower level of care ▪Unwitnessed respiratory arrest

slide-57
SLIDE 57

Monitoring Recommendations

▪Frequently assess VS, O2 sat, DTR’s, and level of consciousness, FHR and uterine activity ▪Assess for signs of toxicity (visual changes, somnolence, flushing, muscle paralysis, loss of patellar reflexes) or pulmonary edema and notify the MD if observed ▪Subsequent assessment

  • Every 15 min for the 1st hour
  • 30 min for the 2nd hour
  • Hourly
slide-58
SLIDE 58

Beta-Mimetic Terbutaline

  • Mechanism

– Beta-2 stimulation → ↑ cyclic AMP, ↓ Calcium

  • Efficacy

– May delay delivery by 2 to 7 days

  • Rationale

– Effective short-term arrest of contractions

  • Safety and side effects – significant and frequent

– Maternal tachycardia, pulmonary edema, glucose intolerance – should only be given as inpatient – Not used as a 1st line or with OB patients with cardiac dz

– Dose

– Terbutaline 0.25 mg subcutaneously only, every 2 hr x 2

ACOG Practice Bulletin. #43, 2005: Normal and Problem Pregnancies, 4th ed., 2002; Preterm birth, Williams Obstetrics, 22nd ed.

2011 FDA issues warning

slide-59
SLIDE 59

Top 10 reported medications errors in OB

  • 1. Ampicillin
  • 2. Oxytocin
  • 3. Ibuprofen
  • 4. Cefazolin
  • 5. Oxycodone
  • 6. Ketoralac
  • 7. Magnesium sulfate
  • 8. Terbutaline
  • 9. Gentamycin

10.Meperidine

Ciarkowski,S., et al. (2010)

slide-60
SLIDE 60

Most common OB meds Associated with Patient Harm

▪Oxytocin ▪Magnesium Sulfate Terbutaline ▪Terbutaline

slide-61
SLIDE 61

Medical-legal Claims

▪21.9% of claims involving neurologically impaired babies ▪14.7% of claims involving stillbirth or neonatal death: included management of oxytocin ▪~ 1/2 of all paid claims involve allegation of oxytocin misuse

▪ Clark, Belfort & Dildy, (2006)

slide-62
SLIDE 62

Induction of Labor Number 107, August 2009 Replaces Practice bulletin 10, Committee Opinion Numbers: 228, 248, 283

▪Classify indication and contraindications ▪Describes the various agents/methods used for IOL ▪Summarize effective agents based on outcome data ▪Outline the requirements for safe clinical use

slide-63
SLIDE 63

ACOG Recommendations

▪Use National Institute of Child Health and Human Development (NICHD) terminology throughout the protocol ▪Clearly explain the purpose of the protocol ▪Describe pre-induction assessment of the patient

  • strongly recommend incorporating pre-induction

checklist ▪State any pre-induction documentation requirements ▪List the contraindications to labor induction

slide-64
SLIDE 64

▪Describe the intrapartum physician and/or nursing assessment and documentation that may be required

  • strongly recommend utilizing a checklist as part of the
  • ngoing assessment

▪List the parameters for discontinuation of the induction agent ▪Describe in detail interventions to be used if tachysystole, FHR abnormalities or other complications occur ▪Outline the notification process of providers should the induction agents be discontinued, or when nursing interventions do not readily resolve tachysystole, fetal heart rate abnormalities or other complications

slide-65
SLIDE 65

Oxytocin Checklist

▪The use of a checklist is highly recommended when administering oxytocin. ▪Checklists provide prerequisites at the point of patient care to safely initiate oxytocin and help to identify situations that require its discontinuation. ▪The Hospital Corporation of America (HCA) and the Institute of Healthcare Improvement (IHI) have developed oxytocin checklists that could be incorporated into your institution’s Pitocin protocol.

slide-66
SLIDE 66

“In use” oxytocin checklist HCA Perinatal Safety Initiative

Recommended Oxytocin “In Use” Checklist for Women with Term Singleton- Babies ▪“This Oxytocin “In Use” Checklist represents a guideline for care: however, individualized medical care is directed by the physician.” ▪Checklist will be completed every 30 minutes. Oxytocin should be stopped or decreased if the following checklist cannot be completed.

▪Date and time completed _____________

slide-67
SLIDE 67

Oxytocin checklist : Fetal Assessment indicates:

▪ At least 1 acceleration of 15 bpm x 15 seconds in 30 minutes or adequate variability ▪ for 10 of the previous 30 minutes. ▪ No more than 1 late deceleration occurred. ▪ No more than 2 Variable decelerations exceeding 60 seconds in duration and ▪ decreasing greater than 60 bpm from the baseline within the previous 30 minutes.

slide-68
SLIDE 68

Oxytocin checklist : Uterine Contractions

▪ No more than 5 uterine contractions in 10 minutes for any

20 minute interval ▪No two contractions greater than 120 seconds duration ▪Uterus palpates soft between contractions ▪If IUPC is in place, MVU** must calculate less than 300 mm Hg and the baseline resting tone must be less than 25 mm Hg. ▪*If Oxytocin is stopped the Pre-Oxytocin Checklist will be reviewed before Oxytocin is reinitiated. ▪** MVU = Montevideo Units

slide-69
SLIDE 69

Results: Checklist based protocol

▪Significant decrease in max rates of

  • xytocin without lengthening labor or

increasing operative interventions. ▪Newborn outcomes improved ▪C/S rate dropped from 23.6% to 21% in 1 year ▪A 50% decrease in adverse outcome claims

slide-70
SLIDE 70

Oxytocin (Pitocin) Induction and Augmentation of Labor

Policy and Procedure: BC.20 BIRTH CENTER – Pt. Care

▪ 8 Pages ▪ HISTORY OF THE POLICY

  • Issue Date: January 2001

▪ VIII. APPENDIX

  • Appendix A: Bishop Scoring System
  • Appendix B: Chart of Oxytocin doses in ml/hr
  • Appendix C: Montevideo Units
slide-71
SLIDE 71

Staffing

▪1:1 Nursing

▪ “If an RN is not available to clinically evaluate the

effects of the oxytocin infusion at least every 15 min, the infusion should be discontinued until that level of care is available.”

▪ (AAP & ACOG, 2002 and AWHONN, 2002, 2010)

slide-72
SLIDE 72

Staffing the Nurse: Patient Ratio

▪1:2 during induction/augmentation with oxytocin (AAP and ACOG Guidelines for Perinatal Care, 2007) ▪1:1 with high risk and active management

  • severe preeclampsia, during the active phase of the first

stage of labor

  • second stage of labor. A nurse must be able to clinically

evaluate the effects of oxytocin at least every 15minutes (AAP & ACOG, 2007). ▪The oxytocin infusion should be discontinued if this level of nursing care cannot be provided. A LIP who has privileges to perform a cesarean birth should be readily available

▪ (AAP & ACOG, 2007)

slide-73
SLIDE 73

Opioids and Patient Controlled Anesthesia (PCA).

  • 1. Prescribing safety

a) Clear pain assessment b) Standardized order set

  • 2. Dispensing safety

a) Prefilled labeled syringes b) Standardized concentration

  • 3. Administration safety

a) Standardized infusion pumps (consider bar-coded technology) b) Education of patient regarding safe use of PCA c) No button use by proxy – only the patient uses the PCA button d) Independent double checks when changing syringes or changing infusion rates

  • 4. Monitoring safety

a) Continuous pulse-oximetry b) Standardized monitoring parameters c) Use sedation scores

slide-74
SLIDE 74

ACOG COMMITTEE OPINION

Number 447 • December 2009 (Replaces No. 286, October 2003)

▪Efforts to reduce the occurrence of these errors should be ongoing. ▪Computerized physician order entry systems can be effective in reducing prescribing errors, they are costly and may not collect data that support quality improvement activities. ▪In the absence of computerized physician order entry systems, the following steps should be adopted to reduce errors in prescribing and administering medications : ▪Improve legibility of handwriting ▪Avoid use of nonstandard abbreviations

slide-75
SLIDE 75

ACOG COMMITTEE OPINION Number 447 • December 2009 (Replaces No. 286, October 2003)

▪Check for drug allergies and sensitivities ▪Always use a leading 0 for doses of less than 1 unit (eg, 0.1 mg, not .1 mg), and never use a trailing 0 after a decimal (eg, 1 mg, not 1.0 mg): “always lead, never follow” ▪All verbal orders should be written down by the individual receiving the order and read back.

slide-76
SLIDE 76

Strategies used by Critical Care Nurses to Identify, Interrupt, and Correct Medical Errors

Henneman, E. A., et al. (2010).

▪To describe error recovery strategies used by critical care nurses ▪Collected data from audio taped focus groups

  • 20 nurses from 5 CCU’s at 4 medical centers

▪17 strategies were identified

  • 8 Identify
  • 3 Interrupt
  • 7 Correct
slide-77
SLIDE 77

Strategies Continued: Nurses use strategies to Identify Errors

Henneman, E. A., et al. (2010).

  • 1. Knowing the patient – history, plan, report, family
  • 2. Knowing the “players” - MD, previous RN
  • 3. Knowing the plan of care – shift report, rounds,
  • missions
  • 4. Surveillance – organize room, check drips
  • 5. Knowing policy/procedure – aware of monitoring
  • 6. Double-checking – “they want me to do this?”
  • 7. Using systematic processes – checklists, report

forms

  • 8. Questioning *– “Would you review the orders with

me?” *Novice or Physician

slide-78
SLIDE 78

Strategies Continued: IDENTIFY ERRORS

Henneman, E. A., et al. (2010).

Nurses used 3 strategies to interrupt errors:

  • 1. offering assistance - help instead of confront

(saving face)

  • 2. clarifying - don’t say “no” say “why”
  • 3. verbally interrupting - hold on – don’t do anything
  • stop

The nurses ability to interrupt was influenced by:

  • experience and confidence
  • support of other nurses / opinion poll
  • fear / perceived intimidation
  • prior experience / regret
slide-79
SLIDE 79

Strategies Continued: IDENTIFY ERRORS

Henneman, E. A., et al. (2010).

Nurses used 6 strategies to correct errors:

  • 1. Persevering – unrelenting attention, phone calls, pages
  • 2. Being physically present – face to face
  • 3. Reviewing or confirming the plan of care – Ask “why”
  • 4. Offering options – Can we give a one time dose? Ask “if”
  • 5. Referencing standards or experts – reference expert/

research article

  • 6. Involving another nurse or physician – Chain of command
slide-80
SLIDE 80

Strategies Continued: IDENTIFY ERRORS

Henneman, E. A., et al. (2010).

▪Nurses reported feeling :

  • Frustrated
  • Challenged
  • Compelled
  • Push harder, chase them down, get in their face

▪Avoided some formal leaders

  • Nurses or MD’s that were overly critical or intimidating

▪Conclusion

  • Nursing vigilance can prevent potentially dangerous

situation from reach or harming the patient

slide-81
SLIDE 81

When a medication error occurs…

▪Full disclosure of errors to patients and families

  • Institute policy
  • Must be timely
  • Must be complete
  • Institute support for those involved
  • Positive outcomes

Institute for Safe Medication Practice (2010)

slide-82
SLIDE 82

Interventions Committee – Error Review

▪Fair and Just Culture required ▪All “errors” tracked and catalogued, regardless of whether they reach the patient or cause harm ▪Errors viewed as systems failures, with examination of policies, EHR functionality, workflow issues, etc. ▪Recommendations made for templates, policies, workflow, and EHR functionality ▪Mechanism for dealing with individuals with performance issues

Institute for Safe Medication Practice (2010)

slide-83
SLIDE 83

The Principles of the Program Behavioral Skills (CRM)

  • Know your

environment

  • Anticipate and plan
  • Assume the

leadership role

  • Communicate

effectively

  • Distribute work load
  • ptimally

Allocate attention Wisely Utilize all available information Utilize all available resources Call for help early enough Maintain professional behavior

slide-84
SLIDE 84

Know Your Environment

▪Sounds simple but it’s not ! ▪Emergency medications or equipment that is rarely used –where found?

  • Triage → OR→

‒arm boards, smart pump, pressure bags, rapid infuser ▪Equipment and supplies move ▪Staff vacations, relief/ float staff

slide-85
SLIDE 85

Instrument & Supply Room

Access to Emergency Supplies

▪Rearranged supplies and labeled bins ▪Stocked Emergency supplies in red bins & moved to upper shelves ▪Re-labeled frequent use bins with known names ▪Grouped related itemss

slide-86
SLIDE 86

OB Hemorrhage Cart: 2014

▪Quick access to emergency supplies ▪Refrigerator for meds ▪Establish necessary items and par levels ▪Label drawers/compartments ▪Include checklists ▪Develop process for checking and restocking ▪Educate nursing and physician staff

McNulty, 2014

slide-87
SLIDE 87

87

Draft 1.2

slide-88
SLIDE 88

Comprehensive maternal hemorrhage protocols reduce the use of blood products and improve patient safety

Shields, L., et. al., (2014) AJOG

▪ Checklist for protocol and data compliance

❑Risk assess ❑Correct blood bank request ❑Quantified blood loss ❑Correct lab results were obtained ❑> 2 Uterotonics give w/o MD present ❑Blood given per protocol

Safehealthcareforeverywoman.org

slide-89
SLIDE 89

A systematic approach to the identification and classification of near-miss events on labor and delivery in a large, national health care system Clark, S., et. al., (2012) AJOG

▪Systematic approach to identify near-miss events on L&D

  • Medication errors were the highest reported

‒ Temporary verses permanent harm

  • MD response and decision making → Greatest potential
  • f harm
  • Barriers in place to reduce harm

‒ Weaknesses (Holes) ‒ Holes align

  • Institutions react to harmful event →Interruption of work

flow ‒ Reactive

  • IOM suggests voluntary reporting of near-miss

‒ Proactive

slide-90
SLIDE 90

Intimidating and Disruptive Behaviors

▪Foster medical errors ▪Contributes to poor patient satisfaction ▪Contributes to preventable adverse

  • utcomes

▪Increases the cost of care ▪Causes qualified clinicians, administrators and managers to seek new positions in more professional environments

JACHO Sentinel Event Alert, # 40, 7/08

slide-91
SLIDE 91
slide-92
SLIDE 92

Let’s make a Difference

  • Medical errors should not be criminalized
  • Fear is a major barrier to action
  • Our actions need to focus on patient safety.
slide-93
SLIDE 93

Promote a Culture of Safety

slide-94
SLIDE 94

Promote a Culture of Safety

The people who cared for their Mom are so sorry and we’re trying to learn from our mistakes. We’re working hard with all individuals at all levels to identify safety threats, and together we’ll find answers and get better at speaking up for patients like their Mom. We promise to do our best to create hospitals that are safe places to work free of fear and retribution. And because of the courage of their Dad and his work, nurses and doctors are better able to protect patients like their Mom and we have learned from this terrible mistake and it won’t happen again.

slide-95
SLIDE 95

Was “Just A Routine Operation.”

▪Martin Bromiley lost his wife in 2007. ▪He identifies, ‘we are all wrong no matter how good we are’. ▪We need people around us to tell us. ▪Be open to suggestions. Listen to your team. Step up and lead. Clear communication is key.

slide-96
SLIDE 96

Summary

▪ Medication delivery is a complex multidisciplinary process.

▪The root causes of medications errors are multifactorial. ▪Nurses should clearly understand what constitutes a medication error. ▪A safe non-punitive work environment is essential for errors to be accurately reported and evaluated and to bring about change. ▪Health care providers need to work together to review errors and implement strategies that promote reliable,

safe systems.

slide-97
SLIDE 97

Happy Nurses’ Week!

▪ zdoggmd.com/ehr-state-of-mind/ ▪ http://zdoggmd.com/youre-welcome/

slide-98
SLIDE 98

Nurses are being increasingly recognized for their role in reducing medical errors. Happy Nurses’ Week!

Th Thank k You

  • u!

Tha Thank nk yo you als u also

  • to

to Val alerie erie Huw uwe for

  • r

he her r me ment ntorship.

  • rship.

Meghan.duck@ucsf.edu

slide-99
SLIDE 99
slide-100
SLIDE 100

References

▪ACOG. (2009). Obstetrics & Gynecology. Volume 114 - Issue 6 - ppg 1424-1427 Committee Opinion

  • No. 447: Patient Safety in Obstetrics and
  • Gynecology. doi: 10.1097/AOG.0b013e3181c6f90e

▪ACOG Practice Bulletin. #43, (2005). Normal and Problem Pregnancies, 4th ed., 2002; Preterm birth, Williams Obstetrics, 22nd ed.

  • Ciarkowski,S., et al. (2010)

▪Clark, A. et al. (2012). Clinical Nurse Specialists. ▪Clark, S. (2008). Maternal death in the 21st Century. Am J Obstet Gynecol,.

slide-101
SLIDE 101

▪Clark, Belfort & Dildy, (2006) ▪Flanders & Clark; Clinical nurse specialist (2010), vol 24 (6) ▪Henneman, E. A., et al. (2010). ▪Kacmar, RM., Mhyre, JM. (2015). Obstetric Anesthesia Patient Safety: Practices to Ensure Adequate Venous Access and Safe Drug Administration During Transfer to the Operating Room for Emergency Cesarean Delivery. Anesthesia Patient Safety Foundation ▪McNulty, 2014 ▪Philadelphia Patient Safety Advisory. (2009). Dec 16;6 (Suppl 1):1-6. ▪Shields, L., et. al., (2014) AJOG ▪Stetina, P. et al (2005)